PT - JOURNAL ARTICLE AU - Gao, Xu AU - Jiang, Meijie AU - Huang, Ninghao AU - Guo, Xinbiao AU - Baccarelli, Andrea A. AU - Huang, Tao TI - Long-term air pollution, cardiometabolic multimorbidity, and genetic susceptibility: a multi-state modeling study of 415,855 participants AID - 10.1101/2022.09.15.22280006 DP - 2022 Jan 01 TA - medRxiv PG - 2022.09.15.22280006 4099 - http://medrxiv.org/content/early/2022/09/17/2022.09.15.22280006.short 4100 - http://medrxiv.org/content/early/2022/09/17/2022.09.15.22280006.full AB - Background Cardiometabolic multimorbidity (CMM) with at least two cardiometabolic diseases (CMDs) including type II diabetes (T2D), ischemic heart disease (IHD), and stroke, is a global health problem with multiplicative mortality risk and deserves to be investigated as a top priority. Although air pollution is a leading modifiable environmental risk for individual CMD, its impacts on CMM progression were poorly understood.Objective To elucidate the impact of air pollution on CMM progression, individually and in the context of genetic preposition.Design Multi-state modeling cohort study.Setting Data were extracted from the UK Biobank.Participants 415,855 eligible UK Biobank adults that were free of CMDs at baseline.Measurements Annual concentrations of particulate matter (PM) with a diameter of ≤2.5 μm (PM2.5), 2.5-10 μm (PM2.5-10), and ≤10 μm (PM10), and nitrogen oxides (NOx and NO2) were estimated using Land Use Regression model.Results During a median follow-up of 8.93 years, 33,375 participants had a first CMD (FCMD), and 3,257 subsequently developed CMM. PM2.5, PM10, NO2, and NOx levels, as well as their combined exposure were associated with increased FCMD risks and even higher risks of CMM. Particularly, per a 5-μg/m3 increase in PM2.5, risks for FCMD and CMM increased by 27% (95% confidence interval: 20%-34%) and 41% (18%-68%), respectively. By FCMD types, participants with IHD had a higher risk of CMM than those with T2D or stroke. Eighty-five CMD-related genetic variants were associated with CMM trajectories in our study and associations of air pollution with FCMD and CMM risks could be aggravated progressively with increasing genetic risks.Limitations Other major air pollutants including ozone and SO2 were not considered due to the data availability.Conclusions Air pollution has profound adverse health impacts on the progression of CMM through multi-stage dynamics, especially for individuals with IHD and high genetic risk.Competing Interest StatementThe authors have declared no competing interest.Funding StatementDr. Xu Gao was supported by grants from the Peking University (BMU2021YJ044) and China CDC Key Laboratory of Environment and Population Health (2022-CKL-03).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:UK Biobank Resource under Application Number 44430. The UK Biobank data are available on application to the UK Biobank (www.ukbiobank.ac.uk/).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData are available in a public, open access repository. This research has been conducted using the UK Biobank Resource under Application Number 44430. The UK Biobank data are available on application to the UK Biobank (www.ukbiobank.ac.uk/).